Parenchyma proliferation is accompanied by a peculiar modification of the cholesterol metabolism involving both the growing tissue and the plasma compartment. The increase of cholesterol synthesis and uptake has been largely described in the literature and mainly ascribed to the increased requirement of cholesterol for new membrane biogenesis. The dramatic reduction of cholesterol efflux, which probably contributes to the increase of cholesterol esterification and accumulation, has also been largely described, although, further to acting as a prompt pool for membrane biogenesis requirements, its significance and possible influence on cholesterol homeostasis during growth has been almost completely neglected. In this short review, the most widely known modifications and new insights into the cholesterol metabolism during the growth of normal and tumoral cells will be discussed. Particular attention will be paid to the most widely known modifications of cholesterol storage and efflux. The possible implication of proteins in membrane cholesterol translocation causing cholesterol to be directed towards the ER for esterification by ACAT rather than being released by the appropriate external acceptor, i.e. HDL, during proliferation will be discussed.
Keywords:Membrane cholesterol, HDL-C, cell proliferation, signal transduction.
Cholesterol metabolism in non-growing cellsWith the exception of specialised cells such as hepatocytes, the majority of resting cells synthesise cholesterol only virtually, with the minimal amounts of the required sterols being obtained by an external source (via lowdensity lipoprotein (LDL) receptor), intracellular cholesterol esterification and efflux also being absent, in accordance with the low membrane turnover present in this condition. Under normal conditions, intracellular cholesterol homeostasis utilises a complex network of reactions capable of providing an adequate supply of cholesterol while avoiding possible conditions of toxicity for the cells. In the majority of cells, the cholesterol supply is regulated by the balance between endogenous synthesis in the endoplasmic reticulum (ER), under the control of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCoA-R), and uptake of exogenous cholesterol, involving endocytosis of the LDL receptor (LDL-r) complex [1]. Toxic conditions produced by excess free cholesterol can be avoided in several ways: by down-regulating cholesterol synthesis and uptake, by promoting esterification by acyl-CoA:cholesterol acyltransferase (ACAT) in the ER [2], and/or by transport to the plasma membrane with subsequent delivery to an external acceptor, i.e. highdensity lipoproteins (HDL) [3].However, it is a well-established fact that a pool of cholesterol completes a cycle to the membrane and returns to the ER with a half-time of 40 min [4], and numerous studies have been undertaken to clarify the mechanisms and the proteins involved in the transport of such a highly hydrophobic lipid between the various intracellular compartments [5][6][7].With regard to cholester...